Prognostic Value of ctDNA Mutation in Melanoma: A Meta-Analysis
Purpose. Melanoma is the most aggressive form of skin cancer. Circulating tumor DNA (ctDNA) is a diagnostic and prognostic marker of melanoma. However, whether ctDNA mutations can independently predict survival remains controversial. This meta-analysis assessed the prognostic value of the presence o...
Main Authors: | Yang Zheng, Hongyan Sun, Lele Cong, Chenlu Liu, Qian Sun, Nan Wu, Xianling Cong |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | Journal of Oncology |
Online Access: | http://dx.doi.org/10.1155/2021/6660571 |
Similar Items
-
Prognostic value of plasma EGFR ctDNA in NSCLC patients treated with EGFR-TKIs.
by: Chengjuan Zhang, et al.
Published: (2017-01-01) -
The Prognostic Value of ctDNA and bTMB on Immune Checkpoint Inhibitors in Human Cancer
by: Jiayan Wei, et al.
Published: (2021-10-01) -
The diagnostic value of circulating tumor cells and ctDNA for gene mutations in lung cancer
by: Lyu M, et al.
Published: (2019-04-01) -
ctDNA Concentration, MIKI67 Mutations and Hyper-Progressive Disease Related Gene Mutations Are Prognostic Markers for Camrelizumab and Apatinib Combined Multiline Treatment in Advanced NSCLC
by: Yao Chen, et al.
Published: (2020-09-01) -
Clinical Value of ctDNA in Hematological Malignancies (Lymphomas, Multiple Myeloma, Myelodysplastic Syndrome, and Leukemia): A Meta-Analysis
by: Xiangyu Tan, et al.
Published: (2021-03-01)